Long-term treatment of subclinical diabetic peripheral neuropathy with aldose reductase inhibitor

Electroencephalography and Clinical Neurophysiology ◽

10.1016/0013-4694(93)90956-v ◽

1993 ◽

Vol 87 (2) ◽

pp. S29

Author(s):

F.P. Serra ◽

C. Canale ◽

G. Nolfe ◽

V. Palma ◽

F. Rotondi ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

Diabetic Medicine ◽

10.1111/j.1464-5491.2008.02490.x ◽

2008 ◽

Vol 25 (7) ◽

pp. 818-825 ◽

Author(s):

N Hotta ◽

R. Kawamori ◽

Y. Atsumi ◽

M. Baba ◽

H. Kishikawa ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats

Journal of Diabetes and its Complications ◽

10.1016/1056-8727(94)90007-8 ◽

1994 ◽

Vol 8 (1) ◽

pp. 27-32 ◽

Author(s):

Noriaki Kato ◽

Kuniharu Mizuno ◽

Akira Matsubara ◽

Kazumasa Nakano ◽

Masayasu Kurono ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Reductase Inhibitor ◽

Diabetic Rats ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Diabetes Care ◽

10.2337/dc05-2370 ◽

2006 ◽

Vol 29 (7) ◽

pp. 1538-1544 ◽

Author(s):

N. Hotta ◽

Y. Akanuma ◽

R. Kawamori ◽

K. Matsuoka ◽

Y. Oka ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Diabetes Complications ◽

Aldose Reductase Inhibitor ◽

Clinical Effects

Download Full-text

The effects of long-term treatment of streptozotocin-diabetic rats with an aldose reductase inhibitor

Experimental Eye Research ◽

10.1016/0014-4835(83)90027-1 ◽

1983 ◽

Vol 37 (5) ◽

pp. 507-515 ◽

Author(s):

R. Poulsom ◽

R.P. Boot-Handford ◽

H. Heath

Keyword(s):

Aldose Reductase ◽

Reductase Inhibitor ◽

Diabetic Rats ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment ◽

Streptozotocin Diabetic Rats

Download Full-text

Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats

Journal of Pharmacological Sciences ◽

10.1254/jphs.08071fp ◽

2008 ◽

Vol 107 (3) ◽

pp. 340-348 ◽

Author(s):

Takafumi Matsumoto ◽

Yoshiyuki Ono ◽

Akemi Kuromiya ◽

Kaoru Toyosawa ◽

Yoshinaka Ueda ◽

...

Keyword(s):

Diabetic Neuropathy ◽

Aldose Reductase ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Cataract Formation ◽

Long Term Treatment

Download Full-text

Effect of an Aldose Reductase Inhibitor on Diabetic Peripheral Neuropathy

Archives of Neurology ◽

10.1001/archneur.1981.00510020091017 ◽

1981 ◽

Vol 38 (2) ◽

pp. 133 ◽

Author(s):

Antonio Culebras

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Diabetic Peripheral Neuropathy: Effect of An Aldose Reductase Inhibitor

Clinical Science ◽

10.1042/cs065019pb ◽

1983 ◽

Vol 65 (3) ◽

pp. 19P-20P

Author(s):

I.G. Lewin ◽

I.A.D. O'Brien ◽

M.H. Morgan ◽

R.J.M. Corrall

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Clinical and Neurophysiological Studies of Aldose Reductase Inhibitor Ponalrestat in Chronic Symptomatic Diabetic Peripheral Neuropathy

Diabetes ◽

10.2337/diab.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy

Diabetes ◽

10.2337/diabetes.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor

The American Journal of Medicine ◽

10.1016/0002-9343(85)90505-4 ◽

1985 ◽

Vol 79 (5) ◽

pp. 13-17 ◽

Author(s):

Douglas A. Greene ◽

Sarah A. Lattimer

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Recent Advances

Download Full-text